According to the report, employer spending on GLP-1 drugs doubled in a single year, rising from $11 to $24 per member per month. GLP-1s now account for 10.5% of all prescription drug claims, up from 6.9% in 2023.

The Department of Justice has obtained a $3.4 million default judgement against a Nebraska pharmacist and pharmacy company over allegations of fraudulent billing to Medicare and Medicaid.

A federal court decision voids the fee as an unlawful tax imposed without congressional authorization, resetting compliance expectations for employers and setting up a likely appeal.

The Clear Healthcare Expense Cost Knowledge (CHECK) Act increases disclosure obligations for PBMs, TPAs and insurers while tightening billing timelines and penalties across the health care system.

Democrats warn of ACA marketplace disruption, workforce reductions and erosion of core public health programs.

The regulator approves the acquisition contingent on the sale of seven surgery centers across five metro markets, citing risks to pricing and quality in key outpatient specialties.

Completing a single drug prior authorization can take up to 64 minutes and add more than $60 in costs.

About 28 million Americans lacked health insurance in 2025.